Marubeni Corporation (hereinafter, "Marubeni") has been selected as a brand for the 2024 Health & Productivity Stock Selection, jointly organized by the Japanese Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange (TSE).

This selection is for outstanding listed enterprises on TSE engaging in health and productivity management*1, in which enterprises focus on and strategically carry out efforts with regard to their employees’ and other workers’ health from a management perspective. Fifty-tree enterprises in 27 industries have been selected as brands for the 2024 Health & Productivity Stock Selection with Marubeni chosen as one of 5 companies to represent the wholesale trade category. This is the third time Marubeni has been selected for two consecutive years following 2023, and it is also the seventh consecutive year the company has been certified as a “White 500” company.

Marubeni is continually implementing and expanding health-related initiatives, focusing on four main themes for its health and productivity management policies: improving health literacy, strengthening countermeasures against cancer and lifestyle-related diseases, strengthening mental health measures, and strengthening initiatives for maintaining and promoting women’s health.

Employees are a vital asset for Marubeni, and their health is of paramount importance. Therefore, Marubeni is working to create an environment where each employee can autonomously and proactively take steps to maintain and promote their health. Marubeni will work on promoting health and productivity management as well as deepening human capital management into the future to support employees’ success, with these efforts actively used to facilitate growth of the Marubeni Group.

Examples of Initiatives:
・Strengthening countermeasures against cancer and lifestyle-related diseases: In addition to providing assistance for health check-ups for employees over 35 years old and full support for brain check-ups for employees at specific ages (45, 50, 55, and 60 years old) starting from FY2023, Marubeni has newly introduced full assistance for colonoscopy exams for employees at specific ages to promote early detection and response to diseases. Furthermore, from October 2023, Marubeni has introduced an “Advanced Medical Treatment Support System” where the company subsidizes the treatment costs for employees who receive advanced medical treatments designated by the Ministry of Health, Labour and Welfare for cancer or other illnesses.
・Strengthening initiatives for maintaining and promoting women’s health: Marubeni contributes to “creating an environment to ensure women can continue thriving at work,” which is one of the basic philosophies of the Female Empowerment at Work 2.0 policy*2, by introducing the “Marubeni Femtech Program*3.”

*1 “Kenkokeiei” (Health and Productivity Management) is a registered trademark of the NPO Kenkokeiei Kenkyukai (“Society for the Management of Company and Employee Health”).
*2 Related News Release: “New Policy for Promoting Female Empowerment at Work” (https://www.marubeni.com/en/news/2022/release/00057.html)
*3 A digital healthcare service which supports working women with concerns caused by menstrual cycles, including PMS, as well as menopausal symptoms through online consultation and prescription of low dose oral contraceptives and herbal medicine as needed. The service also helps promote mutual understanding among colleagues through online seminars about women’s health issues in which employees of all genders are invited to participate.

METI News Release (in Japanese): https://www.meti.go.jp/press/2023/03/20240311003/20240311003.html
Marubeni Group Health and Productivity Management Policy: https://marubeni.disclosure.site/en/themes/24/